Jump to content

Reading list

The challenge papers are the best starting point for the capacity question.

Human challenges

Begin with the probe of GnRH neuronal function in abiding idiopathic hypogonadotropic hypogonadism, then read the cohort whose disorder had reversed and the responses during pubertal transition in boys. Their different populations give the diagnostic idea its interest.

For the changing response over time, the intravenous infusion experiment in hypothalamic amenorrhea and the repeated-exposure study make a revealing pair. They ask related questions with different research protocols.

Beyond the challenge

The food-intake experiment and the anxiety trial show why an LH response needs a specified endpoint beside it. The mouse receptor-knockout metabolism experiment approaches metabolism through a different intervention.

For a broader survey, the clinical-status systematic review published in 2025 identified 29 interventional clinical trials from searches through February 2023. That search boundary matters when using it as a map of the literature.

I favour the individual experiments for the arguments on this site. The review helps establish their surroundings; the full source list follows.

  1. Exogenous kisspeptin administration as a probe of GnRH neuronal function in patients with idiopathic hypogonadotropic hypogonadism ↗
  2. The GPR54 gene as a regulator of puberty ↗
  3. Kisspeptin excites gonadotropin-releasing hormone neurons through a phospholipase C/calcium-dependent pathway regulating multiple ion channels ↗
  4. Kisspeptin Responsiveness Signals Emergence of Reproductive Endocrine Activity: Implications for Human Puberty ↗
  5. Changes in the Responsiveness of the Hypothalamic-Pituitary-Gonadal Axis to Kisspeptin-10 Administration during Pubertal Transition in Boys ↗
  6. KISS1R: Hallmarks of an Effective Regulator of the Neuroendocrine Axis ↗
  7. Increasing LH pulsatility in women with hypothalamic amenorrhoea using intravenous infusion of kisspeptin-54 ↗
  8. Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis ↗
  9. A review of the pathophysiology of functional hypothalamic amenorrhoea in women subject to psychological stress, disordered eating, excessive exercise or a combination of these factors ↗
  10. The effects of kisspeptin on food intake in women with overweight or obesity ↗
  11. Kisspeptin administration stimulates reproductive hormones but does not affect anxiety in humans ↗
  12. Impaired kisspeptin signaling decreases metabolism and promotes glucose intolerance and obesity ↗
  13. Kisspeptin and its current clinical status - a systematic review ↗
  14. Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54 ↗